Csiro Innovation Fund joined Westpac-backed Reinventure to co-lead cybersecurity platform creator Kasada’s latest round, which will help fund recruitment and international expansion.

A consortium involving public-private partnership HTGF has supplied funding to University of Bremen spinout Mirdetect to help a molecular diagnostics blood draw for testicular cancer.

University of Twente-founded cartilage repair injection developer Hy2Care is currently targeting orthopaedic knee applications in veterinary and human healthcare settings.

Based on Clemson University research, 3D cancer cell modelling spinout Kiyatec has increased its total financing to $14.9m with the help of clinical lab operator LabCorp and VC firm VentureSouth.

Scottish Investment Bank and Innovate UK were among those backing University of Strathclyde brain cancer diagnosis spinout ClinSpec Diagnostics.

Cambridge Enterprise and CIC featured in cancer therapy developer PolyProx Therapeutics’ seed round, which will coommercialise research from the university’s pharmacology department.

Founded on inventions from Centre for Quantum Technologies, Speqtral is now set to commercialise its first application for quantum communications satellites.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Dilafor, a portfolio company of Karolinska Development, has attracted investors led by its manufacturing partner Opocrin to take its overall funding to more than $8.3m.

ETH Zurich spinout RosieReality has attracted $2.2m in seed capital led by Redalpine, with a contribution from existing backer Akatsuki.